NCT03559985 (PAeoNy) is a Phase 2 clinical trial of paracetamol in Neuropathic Pain, sponsored by University Hospital, Clermont-Ferrand.

Who is sponsoring NCT03559985?

NCT03559985 is sponsored by University Hospital, Clermont-Ferrand.

What drugs are being tested in NCT03559985?

Interventions in NCT03559985: paracetamol, Placebo comparator.

What condition does NCT03559985 study?

NCT03559985 studies Neuropathic Pain.

Is NCT03559985 still recruiting?

NCT03559985 is currently terminated. Last updated 10 October 2022.

Last reviewed 2022-10-10 · How we verify

NCT03559985: PAeoNy

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Paracetamol and Neuropathic Pain

Terminated Phase 2 Last updated 10 October 2022

What this trial tests

Phase 2 trial testing paracetamol in Neuropathic Pain in 43 participants. Terminated before completion.

Timeline

20 August 2018

Primary endpoint
8 October 2020

31 August 2022

Quick facts

Lead sponsor	University Hospital, Clermont-Ferrand
Phase	Phase 2
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	treatment
Enrollment	43
Start date	20 August 2018
Primary completion	8 October 2020
Estimated completion	31 August 2022
Sites	1 location across France

Drugs / interventions tested

paracetamol (Paracetamol) — full drug profile →
Placebo comparator

Conditions studied

Neuropathic Pain — all drugs for Neuropathic Pain →

Sponsor

University Hospital, Clermont-Ferrand

Who can join

Adults 18 to 65, any sex, with Neuropathic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the analgesic effect of paracetamol in patients suffering from pain with a peripheral neuropathic component in the presence of their usual treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of paracetamol

Trials testing the same drug.

NCT07071012 — Pain Control After Open Radical Nephrectomy: Thoracic Paravertebral Block Versus External Oblique Intercostal Block · NA · completed
NCT05647681 — Analgesic Effect of a New Analgesic Based Gel(Douloff) Versus Oral Paracetamol in Acute Soft Injuries · Phase 1 · unknown
NCT07394491 — Intravenous Paracetamol Versus Intramuscular Tramadol in Shortening the Duration of Labour. · NA · completed
NCT04931693 — PECs Block for Pacemaker Insertion in Children · Phase 4 · completed
NCT06574516 — Pain Management Following Dental Treatment Under General Anesthesia · NA · completed

Other recruiting trials for Neuropathic Pain

Currently open trials in the same condition.

NCT07493213 — USG-Guided Shoulder Injections in Frozen Shoulder · NA · recruiting
NCT07493226 — Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis · NA · recruiting
NCT06398847 — Virtual Reality (VR) Self-Hypnosis Software · NA · recruiting
NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
NCT07436806 — SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery · NA · recruiting

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

NCT07179276 — Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock · NA · recruiting
NCT07476768 — PAINDYS_Characterizing Pain in Fibrous Dysplasia of Bone/McCune-Albright Syndrome: an Exploratory Pilot Study · NA · not yet recruiting
NCT07439146 — Risk of Pneumonia in Intubated Patients in Emergency Situations · not yet recruiting
NCT07427537 — Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients · NA · recruiting
NCT07330856 — Evaluation of Treatments for Dry or Productive Cough · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03559985 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Clermont-Ferrand
Last refreshed: 10 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03559985.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing